Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Black currant seed oil is a botanical extract derived from the seeds of the black currant plant (*Ribes nigrum*). It is notably rich in the omega-6 fatty acid gamma-linolenic acid (GLA) and the omega-3 fatty acid alpha-linolenic acid (ALA). The oil is utilized as a nutraceutical for its anti-inflammatory properties, which are mediated through the metabolism of these essential fatty acids into anti-inflammatory eicosanoids, such as prostaglandin E1, and the competitive inhibition of pro-inflammatory arachidonic acid metabolites. Clinical research has focused on its application in chronic inflammatory conditions, specifically atopic dermatitis and rheumatoid arthritis, where it has shown potential in reducing disease activity and symptoms like joint tenderness. However, clinical utility has been limited by the high pill burden required to achieve therapeutic doses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on black currant seed oil.